Announcements Trials
Browse Landscape

Phase

Phase 2 14Phase 1 7Phase 3 3Phase 1/2 3Phase 2/3 2Phase 4 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 10Stomach Neoplasms 4Colonic Neoplasms 3Rectal Neoplasms 2Neoplasm Metastasis 2Liver Neoplasms 2Postoperative Complications 1Pancreatic Neoplasms 1Neurotoxicity Syndromes 1Neoplasms 1Locally Advanced Colorectal Cancer 1HER-2 Positive Gastric Cancer 1Gastrointestinal Stromal Tumors 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Colorectal Cancer Metastatic 1Colon Cancer Liver Metastasis 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Bile Duct Neoplasms 1Appendiceal Neoplasms 1Anus Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

Sevoflurane 1Oxaliplatin 1Desflurane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Gallbladder Neoplasms × Oxaliplatin × Clear all
NCT00274885 2011-12-05

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

National Cancer Institute (NCI)

Phase 4 Unknown
58 enrolled
GastrointestinalSarcoma

Anus Neoplasms, Appendiceal Neoplasms, Bile Duct Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Neurotoxicity Syndromes, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡